GREAT Pharmacists

by Robert Mangione, Ed.D, R.Ph, Loretta Jay, MA and James Wisner, BBA, MBA. 1.5 CE credits
Description:

Three million Americans have celiac disease, and the only treatment for this life-long ailment is the implementation of a gluten-free diet. As gluten is found in medication, pharmacy care is critical in the treatment of this disorder.

Celiac disease is a genetic, autoimmune disease that damages the small intestines and interferes with the absorption of nutrients from food. When people with celiac ingest gluten, the protein in wheat, barley and rye, the whole body is affected causing a myriad of symptoms.

This common disease affects 1% of the U.S. population, and another 6% of the population is gluten intolerant, greatly increasing the number of people needing to follow the gluten-free diet.

This continuing education activity, presented by NFCA and Pro CE, will provide pharmacists with a reliable understanding of celiac disease and their role in supporting patients with celiac disease and those who are sensitive to gluten.

Click Here to Take the Course »

By clicking the link above, you will be directed to Pro CE's website to complete the course. 

Disclosure

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. Mr. Wisner has disclosed that he has served as a consultant and/or speaker for the Perrigo Company. Dr. Mangione and Ms. Jay report having no relationships to disclose.

Please note: The opinions expressed in this program should not be construed as those of the CE provider or Cardinal Health. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 03-07-2011

Expiration Date: 03-07-2014

Pharmacists
This program is co-sponsored by ProCE, Inc. and the National Foundation for Celiac Awareness. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-999-11-021-H01-P has been assigned to this knowledge-based home-study CE activity (initial release date 03-07-11). This program is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Statements of credit will be issued online upon completion of the program evaluation and the post-test with a score of 70% or higher. No partial credit will be given.

Funding

This program was supported by an unrestricted educational grant from Perrigo.

Perrigo

To Participate

To participate in this Web-based continuing education activity:

1. Review the program description and objectives.
2. View the program by clicking on the link below.
3. Take the online post-test and complete the evaluation by clicking the appropriate link below (i.e. Pharmacists First Time Registration or Returning Users); registration will be required.

Click Here to View this Program


Learning Objectives:

After completing this course, professionals will be able to:
  • Define the etiology of celiac disease, its prevalence and pathophysiology
  • Recognize the signs and symptoms and list major complications of celiac disease
  • Identify potential sources of gluten in medication
  • Describe current United States and international guidelines for labeling gluten in medication
  • Discuss ways that pharmacists and pharmaceutical manufacturers can help patients with celiac disease use medicines safely and effectively
SKU Price
PH $0.00

Please bring any disability or other special learning needs to the attention of NFCA for appropriate accommodation. The NFCA does not discriminate and respects cultural, individual, and role differences, including those based on age, gender, gender identity, race, ethnicity, culture, national origin, religion, sexual orientation, disability, language, and socioeconomic status.